Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
about
Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderlyHeterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesSeasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature reviewThe epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong KongA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusRandomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskEpidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in MexicoOptimal design of intervention studies to prevent influenza in healthy cohortsThe Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.Two years after pandemic influenza A/2009/H1N1: what have we learned?A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific RegionMultivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age childrenHemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infectionAssessing the use of antiviral treatment to control influenza.Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational studyPartial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.Economic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic.A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza VirusThe priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort studyPredictors of influenza a molecular viral shedding in Hutterite communities.Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan.Hallmarks of CD4 T cell immunity against influenzaEffect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009.Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in childrenTowards universal influenza vaccines?Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.Influenza vaccination coverage rate in children: reasons for a failure and how to go forward.No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.The time required to estimate the case fatality ratio of influenza using only the tip of an iceberg: joint estimation of the virulence and the transmission potentialProtective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.Humoral antibody response after receipt of inactivated seasonal influenza vaccinations one year apart in children.Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, CanadaNovel viral vectored vaccines for the prevention of influenza.Advances in the development of universal influenza vaccines.Pediatric influenza vaccination: understanding the T-cell response.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityLong-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.
P2860
Q21560857-20CA13AF-EE03-4227-B8DF-95A1FB32A9A2Q26744622-6ED58F7C-4545-484D-B93C-BEA395F95DE1Q26769664-ACF2F72C-9880-48AF-8CFF-40135F71913CQ27000773-D41F545B-878D-4676-B91A-368FBD40520BQ27316330-D684C0D8-9005-4CDC-8BBF-B19ED3CA1900Q27330166-1B869D8E-9F29-4433-A7B1-4BA3E4BF265CQ28729170-C4038BEB-065F-4C17-B429-BD4F484446D4Q28730583-2395136D-5954-4365-A10B-8FCA8298B968Q30205724-B6B5B8D5-D6F0-4BBE-81E0-2ACA17B13461Q30224656-73FDEF39-8F63-4C6C-BBE2-20E6B34167EFQ30352256-A409828D-F8C3-4B1A-BA61-D8D0A5301D74Q30362089-31405BC2-5EE1-42A8-8C4F-10A8BE6847B8Q30366832-14047B26-31B9-47BC-B53F-60B2BBBF4619Q30367363-264D2431-5503-4452-BB71-E4278807F618Q30369346-2F188D64-B467-4597-9058-C0BB7D49FEBDQ30371873-74EF1A03-7CA0-420A-89D6-6D76F9102E76Q30373077-5CE7FA5E-E02F-421C-99AD-9C2B338D8394Q30383964-5F6727AC-00D5-4983-87AE-0C5730BFE66FQ30384304-F4438937-3951-4F0A-A514-10F91ED816BBQ30392073-A41A8540-623C-4AF9-B42A-B1AE7446724BQ30398711-0F872A25-94C5-496C-988D-FB942CDA14B0Q30398939-B7FAA629-27B1-4633-A7EC-4738F7D170ECQ30400092-24237D86-41E7-415B-9A3A-27385CA52D54Q30400290-780234BB-87FD-4E1B-ADD1-6DC0EF689E53Q30401304-1060A345-1D71-4EEA-8E76-A3588DC67D0AQ30406530-F5FBE440-2917-40E1-9367-9D5EC57BF4A9Q30406576-414DB5B0-7F5C-4AD6-8C56-3709E78B74BEQ30406748-A8587CC6-A09A-4D9E-ACF1-6D1F22242C00Q30409342-F55B0FFF-DCAB-428C-B189-68F2A09C3E53Q30411868-2D1291EC-2372-41E3-89FD-DA9E7DB692B0Q30415608-DBA86177-2C0E-48CB-AAA5-3CED6417D372Q30417409-74C8EDA9-41D5-4AF4-9CF0-D2FCA2587DB0Q30417601-85BBC77E-1BD0-4CC5-80C4-91681D371400Q30417799-C1C6E372-FD37-48ED-A35C-0ACA52982F3AQ30418193-FD6B432F-07F3-476E-A1A8-99BAE09BD6D8Q30418570-A861F58E-74B6-4418-908E-C9BA07103464Q30421502-A2CFF57C-95F7-4E8B-911C-45C3FCC85C75Q30421553-AF29B11D-B948-4952-84E4-A879FA137E2CQ30421682-CB529DBE-5E4E-4405-AA4F-ECABF86DA7FDQ30429185-ABD9EFF6-EB2C-4A8C-BC6F-FCF8A17FCE4C
P2860
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@ast
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@en
type
label
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@ast
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@en
prefLabel
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@ast
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@en
P2093
P50
P356
P1476
Protective efficacy of seasona ...... tion during 2009 in Hong Kong.
@en
P2093
Calvin K Y Cheng
Dennis K M Ip
Edward S K Ma
Susan S Chiu
Winnie Wai
P304
P356
10.1086/657311
P407
P577
2010-11-10T00:00:00Z